{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:48:59Z","timestamp":1771030139346,"version":"3.50.1"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ALIVE Foundation"},{"name":"CIBEREHD","award":["CB06\/04\/0081"],"award-info":[{"award-number":["CB06\/04\/0081"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III-FEDER fund","doi-asserted-by":"publisher","award":["PI17\/01089"],"award-info":[{"award-number":["PI17\/01089"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union projects Hecatos","award":["CP-IP 602156-1"],"award-info":[{"award-number":["CP-IP 602156-1"]}]},{"name":"EU-TOXRISK","award":["CP-IP 681002"],"award-info":[{"award-number":["CP-IP 681002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.fct.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T13:50:38Z","timestamp":1530971438000},"page":"196-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-9834","authenticated-orcid":false,"given":"M. Leonor","family":"Fern\u00e1ndez-Murga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-4317","authenticated-orcid":false,"given":"Petar D.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Gom\u00e9z-Lech\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-5804","authenticated-orcid":false,"given":"Ramiro","family":"Jover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2018.07.017_bib1","first-page":"655","article-title":"ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles","volume":"14","author":"Adachi","year":"1991","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4161\/gmic.24706","article-title":"Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host","volume":"4","author":"Alaish","year":"2013","journal-title":"Gut Microb."},{"key":"10.1016\/j.fct.2018.07.017_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.fct.2018.07.017_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623518","article-title":"Hepatic damage by natural remedies","volume":"38","author":"Andrade","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4253\/wjge.v9.i6.282","article-title":"Bladder urothelial carcinoma extending to rectal mucosa and presenting with rectal bleeding","volume":"9","author":"Aneese","year":"2017","journal-title":"World J. Gastrointest. Endosc."},{"key":"10.1016\/j.fct.2018.07.017_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.109.028407","article-title":"An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes","volume":"38","author":"Ansede","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Antherieu","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib9","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.114.058123","article-title":"Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells","volume":"42","author":"Bachour-El Azzi","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mam.2013.12.001","article-title":"Clinical application of transcriptional activators of bile salt transporters","volume":"37","author":"Baghdasaryan","year":"2014","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.fct.2018.07.017_bib11","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1074\/jbc.270.8.3594","article-title":"Multiple canalicular transport mechanisms for glutathione S-conjugates. Transport on both ATP- and voltage-dependent carriers","volume":"270","author":"Ballatori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2018.07.017_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000374093","article-title":"Preventing drug-induced liver injury: how useful are animal models?","volume":"33","author":"Ballet","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib13","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3748\/wjg.v12.i22.3496","article-title":"Cholangiocyte anion exchange and biliary bicarbonate excretion","volume":"12","author":"Banales","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.fct.2018.07.017_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.108.023317","article-title":"Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice","volume":"37","author":"Beilke","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2013II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.fct.2018.07.017_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2362.2006.01607.x","article-title":"Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis","volume":"36","author":"Bertolotti","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.fct.2018.07.017_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/jhep.2001.23505","article-title":"Drug-induced liver injury: mechanisms and test systems","author":"Bissell","year":"2001","journal-title":"Hepatology, United States"},{"key":"10.1016\/j.fct.2018.07.017_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MCG.0000000000000568","article-title":"Azathioprine and 6-Mercaptopurine-induced liver injury: clinical features and outcomes","volume":"51","author":"Bjornsson","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2012.11.002","article-title":"Drug-induced cholestasis","volume":"17","author":"Bjornsson","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/j.2040-4603.2013.tb00519.x","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.fct.2018.07.017_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/00498254.2012.675093","article-title":"Generation of proliferating human hepatocytes using Upcyte(R) technology: characterisation and applications in induction and cytotoxicity assays","volume":"42","author":"Burkard","year":"2012","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.fct.2018.07.017_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.22683","article-title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing","volume":"49","author":"Byrne","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib28","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.36591","article-title":"The human bile salt export pump: characterization of substrate specificity and identification of inhibitors","volume":"123","author":"Byrne","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2036.2009.04210.x","article-title":"The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy","volume":"31","author":"Castano","year":"2010","journal-title":"Aliment Pharmacol. Therapeut."},{"key":"10.1016\/j.fct.2018.07.017_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib31","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol."},{"key":"10.1016\/j.fct.2018.07.017_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ng1665","article-title":"The origins and uses of mouse outbred stocks","volume":"37","author":"Chia","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.fct.2018.07.017_bib35","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","author":"Church","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2741\/3981","article-title":"Localization status of hepatocellular transporters in cholestasis","volume":"17","author":"Crocenzi","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.fct.2018.07.017_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/dmd.113.056358","article-title":"The role of canalicular ABC transporters in cholestasis","volume":"42","author":"Cuperus","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clinre.2012.08.008","article-title":"NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations","volume":"36","author":"Davit-Spraul","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.fct.2018.07.017_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/17425255.2013.773973","article-title":"Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity","volume":"9","author":"De Bruyn","year":"2013","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/17425255.2014.884069","article-title":"Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools","volume":"10","author":"de Lima Toccafondo Vieira","year":"2014","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib42","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.3892\/etm.2016.3752","article-title":"Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency","volume":"12","author":"Deng","year":"2016","journal-title":"Experimental and therapeutic medicine"},{"key":"10.1016\/j.fct.2018.07.017_bib43","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1517\/17425255.2014.963553","article-title":"Effect of drug transporter pharmacogenetics on cholestasis","volume":"10","author":"Dietrich","year":"2014","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2016.10.008","article-title":"Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: application to develop new predictive biomarkers for early drug development","volume":"263","author":"Donato","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2018.07.017_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","article-title":"Culture and functional characterization of human hepatoma HepG2 cells","volume":"1250","author":"Donato","year":"2015","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.fct.2018.07.017_bib46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/liv.12216","article-title":"Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1\/ABCB11 mutations?","volume":"33","author":"El Sherrif","year":"2013","journal-title":"Liver Int.: Offic. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.fct.2018.07.017_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ajcp\/47.5.598","article-title":"Serum levels of 5'-nucleotidase in disease","volume":"47","author":"Eschar","year":"1967","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.fct.2018.07.017_bib48","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41598-017-05656-8","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: alterations in biosynthesis, enterohepatic circulation, and microbial metabolism","volume":"7","author":"Fader","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2018.07.017_bib49","series-title":"Animal Models of Cholestasis","first-page":"331","author":"Fickert","year":"2013"},{"key":"10.1016\/j.fct.2018.07.017_bib50","first-page":"579","article-title":"Counter-regulatory role of bile acid activated receptors in immunity and inflammation","volume":"10","author":"Fiorucci","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.fct.2018.07.017_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib52","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2015.283","article-title":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury","volume":"110","author":"Fontana","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2011.02.007","article-title":"Causality assessment methods in drug induced liver injury: strengths and weaknesses","volume":"55","author":"Garcia-Cortes","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib54","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.113.054189","article-title":"The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity","volume":"42","author":"Garzel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib55","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fct.2018.07.017_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbamcr.2006.04.014","article-title":"Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration","volume":"1773","author":"Geier","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2018.07.017_bib57","first-page":"1232","article-title":"Drug and toxin-induced bile duct disorders","volume":"15","author":"Geubel","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.fct.2018.07.017_bib59","series-title":"Structural and Functional Hepatocyte Polarity and Liver Disease","first-page":"1023","author":"Gissen","year":"2015"},{"key":"10.1016\/j.fct.2018.07.017_bib60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/15376516.2015.1033074","article-title":"The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid\/rifampicin-induced hepatotoxicity","volume":"25","author":"Guo","year":"2015","journal-title":"Toxicol. Mech. Meth."},{"key":"10.1016\/j.fct.2018.07.017_bib61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/humu.22138","article-title":"ABCMdb: a database for the comparative analysis of protein mutations in ABC transporters, and a potential framework for a general application","volume":"33","author":"Gyimesi","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.fct.2018.07.017_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cld.2012.12.001","article-title":"Nuclear receptors as drug targets in cholestatic liver diseases","volume":"17","author":"Halilbasic","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.22656","article-title":"Hepatic function is preserved in the absence of mature microRNAs","volume":"49","author":"Hand","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib65","first-page":"E158","article-title":"Importance of bicarbonate in bile salt independent fraction of bile flow","volume":"235","author":"Hardison","year":"1978","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.fct.2018.07.017_bib66","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/hep.25591","article-title":"AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function","volume":"55","author":"Hayashi","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/ijms17020201","article-title":"Drug-induced liver injury network causality assessment: criteria and experience in the United States","volume":"17","author":"Hayashi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib68","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/acs.chemrestox.5b00201","article-title":"Inhibition of MDR3 activity in human hepatocytes by drugs associated with liver injury","volume":"28","author":"He","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib69","series-title":"Hepatic 3D Spheroid Models for the Detection and Study of Compounds with Cholestatic Liability","author":"Hendriks","year":"2016"},{"key":"10.1016\/j.fct.2018.07.017_bib70","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ajg.2016.114","article-title":"Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury","volume":"111","author":"Hillman","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3283349eb0","article-title":"Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability","volume":"20","author":"Ho","year":"2010","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.fct.2018.07.017_bib72","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2018.07.017_bib73","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib74","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.fct.2018.07.017_bib75","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2018.07.017_bib76","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2018.07.017_bib77","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cgh.2007.02.036","article-title":"Hepatotoxicity associated with dietary supplements containing anabolic steroids","volume":"5","author":"Kafrouni","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol.: Offic. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.fct.2018.07.017_bib78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/dmd.114.061325","article-title":"No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis","volume":"43","author":"Kagawa","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.1840060334","article-title":"Serum alkaline phosphatase\u2013another piece is added to the puzzle","volume":"6","author":"Kaplan","year":"1986","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","article-title":"Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis","volume":"131","author":"Karlsen","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.06.236","article-title":"Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis","volume":"221","author":"Kienhuis","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2018.07.017_bib82","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.29324","article-title":"A liver-specific gene expression panel predicts the differentiation status of in vitro hepatocyte models","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib83","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1124\/dmd.108.024778","article-title":"Effect of membrane cholesterol on BSEP\/Bsep activity: species specificity studies for substrates and inhibitors","volume":"37","author":"Kis","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib84","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.tiv.2011.11.002","article-title":"BSEP inhibition: in vitro screens to assess cholestatic potential of drugs","volume":"26","author":"Kis","year":"2012","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2018.07.017_bib85","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/hep.28826","article-title":"Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis","volume":"64","author":"Kulkarni","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib86","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.fct.2018.07.017_bib87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.fct.2018.07.017_bib88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000450906","article-title":"Role of the intestinal microbiome in cholestatic liver disease","volume":"35","author":"LaRusso","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib90","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.tiv.2013.07.003","article-title":"Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells","volume":"27","author":"Le Vee","year":"2013","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2018.07.017_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2013.07.001","article-title":"Drug-induced acute liver failure","volume":"17","author":"Lee","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib92","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nbt.3377","article-title":"Long-term culture and expansion of primary human hepatocytes","volume":"33","author":"Levy","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.fct.2018.07.017_bib93","first-page":"1275","article-title":"Drug-induced liver disease","volume":"84","author":"Lewis","year":"2000","journal-title":"Med. Clin."},{"key":"10.1016\/j.fct.2018.07.017_bib94","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1089-3261(05)70079-9","article-title":"Drug- and chemical-induced cholestasis","volume":"3","author":"Lewis","year":"1999","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib96","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.35953","article-title":"Heterozygous inactivation of the nuclear receptor PXR\/NR1I2 in a patient with anabolic steroid-induced intrahepatic cholestasis","volume":"16","author":"Liebe","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.fct.2018.07.017_bib97","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.22370","article-title":"Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury","volume":"48","author":"Lucena","year":"2008","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/mol.116.103390","article-title":"Role of multidrug resistance protein 3 in antifungal-induced cholestasis","volume":"90","author":"Mahdi","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib99","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.fct.2018.07.017_bib100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"4 Pt B","key":"10.1016\/j.fct.2018.07.017_bib101","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2018.07.017_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111864","article-title":"Impact of microbes on the pathogenesis of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)","volume":"17","author":"Mattner","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib103","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2016.05.003","article-title":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","volume":"65","author":"Medina-Caliz","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2018.07.017_bib104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-004-0888-z","article-title":"Incidence of drug-induced liver injury in medical inpatients","volume":"61","author":"Meier","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib106","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib107","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbadis.2018.01.015","article-title":"Mechanisms of canalicular transporter endocytosis in the cholestatic rat liver","volume":"1864","author":"Miszczuk","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2018.07.017_bib108","doi-asserted-by":"crossref","first-page":"G550","DOI":"10.1152\/ajpgi.00364.2005","article-title":"Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep","volume":"290","author":"Mita","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2018.07.017_bib109","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2018.07.017_bib110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1872-034X.2012.01088.x","article-title":"Role of gut microbiota in liver diseases","volume":"43","author":"Miyake","year":"2013","journal-title":"Hepatol. Res. : the official journal of the Japan Society of Hepatology"},{"key":"10.1016\/j.fct.2018.07.017_bib111","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1089-3261(03)00124-7","article-title":"Drug- and chemical-induced cholestasis","volume":"8","author":"Mohi-ud-din","year":"2004","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib112","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib115","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/jhep.2002.33327","article-title":"Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis","volume":"35","author":"Mottino","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tiv.2013.06.024","article-title":"3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies","volume":"28","author":"Mueller","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2018.07.017_bib117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mrgentox.2013.09.008","article-title":"Optimization of upcyte(R) human hepatocytes for the in vitro micronucleus assay","volume":"758","author":"Norenberg","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.fct.2018.07.017_bib118","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOG.0b013e3282f9764b","article-title":"Drug-induced liver injury in 2007","volume":"24","author":"Norris","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib119","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/dmd.104.001909","article-title":"Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms","volume":"33","author":"Nozawa","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2011.11.032","article-title":"Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes","volume":"416","author":"Ogimura","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2018.07.017_bib121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","article-title":"Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes","volume":"34","author":"Oorts","year":"2016","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2018.07.017_bib122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vascn.2015.03.002","article-title":"Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture","volume":"73","author":"Oorts","year":"2015","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.fct.2018.07.017_bib123","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2018.07.017_bib124","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","article-title":"Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11)","volume":"136","author":"Pedersen","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.fct.2018.07.017_bib128","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.molpharmaceut.5b00659","article-title":"Disruption of BSEP function in HepaRG cells alters bile acid disposition and is a susceptive factor to drug-induced cholestatic injury","volume":"13","author":"Qiu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.fct.2018.07.017_bib129","first-page":"1083","article-title":"A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/toxsci\/kfx194","article-title":"Three-dimensional (3D) HepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening","volume":"160","author":"Ramaiahgari","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054472","article-title":"The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation","volume":"8","author":"Renga","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2018.07.017_bib132","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2018.07.017_bib133","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hep.20081","article-title":"Hy's law","volume":"39","author":"Reuben","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib134","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20110184","article-title":"Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications","volume":"121","author":"Roma","year":"2011","journal-title":"Clinical science (London, England: 1979)"},{"key":"10.1016\/j.fct.2018.07.017_bib135","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/dmd.115.067348","article-title":"Upcyte human hepatocytes: a potent in vitro tool for the prediction of hepatic clearance of metabolically stable compounds","volume":"44","author":"Schaefer","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/dmd.117.078238","article-title":"Quantitative expression of hepatobiliary transporters and functional uptake of substrates in hepatic 2D sandwich-cultures: a comparative evaluation of upcyte and primary human hepatocytes","volume":"46","author":"Schaefer","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib138","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib139","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1053\/j.gastro.2009.02.067","article-title":"Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis","volume":"136","author":"Sekine","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2606","article-title":"Dicer is required for proper liver zonation","volume":"219","author":"Sekine","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.fct.2018.07.017_bib141","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib142","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.117.077420","article-title":"Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfation","volume":"45","author":"Sharanek","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2018.07.017_bib143","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1194\/jlr.M400132-JLR200","article-title":"Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4","volume":"45","author":"Shoda","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.fct.2018.07.017_bib144","article-title":"Clinical biochemistry of hepatotoxicity","author":"Singh","year":"2011","journal-title":"J. Clin. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib145","first-page":"363","article-title":"Drug-induced liver toxicity and prevention by herbal antioxidants: an overview","volume":"6","author":"Singh","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.fct.2018.07.017_bib146","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M004531","article-title":"A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes","volume":"51","author":"Song","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.fct.2018.07.017_bib147","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1073\/pnas.0409794102","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury","volume":"102","author":"Stedman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2018.07.017_bib148","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.3748\/wjg.v19.i38.6398","article-title":"New insights in bilirubin metabolism and their clinical implications","volume":"19","author":"Sticova","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2018.07.017_bib149","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/17425255.2011.557067","article-title":"Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis","volume":"7","author":"Stieger","year":"2011","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"Pt 1","key":"10.1016\/j.fct.2018.07.017_bib150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj2840067","article-title":"ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles","volume":"284","author":"Stieger","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.fct.2018.07.017_bib151","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","article-title":"Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid","volume":"46","author":"Stojakovic","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib152","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0399-8320(05)82229-8","article-title":"Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis","author":"Sturm","year":"2005","journal-title":"Gastroenterol Clin Biol., France"},{"key":"10.1016\/j.fct.2018.07.017_bib153","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep4.1088","article-title":"Drug-induced cholestasis","volume":"1","author":"Sundaram","year":"2018","journal-title":"Hepatology Communications"},{"key":"10.1016\/j.fct.2018.07.017_bib154","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1124\/dmd.115.065425","article-title":"Prediction of the clinical risk of drug-induced cholestatic liver injury using an in vitro sandwich cultured hepatocyte assay","volume":"43","author":"Susukida","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.fct.2018.07.017_bib155","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1073\/pnas.1006734107","article-title":"Systemic gut microbial modulation of bile acid metabolism in host tissue compartments","volume":"108","author":"Swann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2018.07.017_bib156","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.fct.2018.07.017_bib157","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2018.07.017_bib158","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","article-title":"Human upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing","volume":"152","author":"Tolosa","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib159","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.fct.2018.07.017_bib160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/j.2040-4603.2013.tb00490.x","article-title":"Hepatocyte polarity","volume":"3","author":"Treyer","year":"2013","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.fct.2018.07.017_bib161","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/mp060020t","article-title":"Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors","volume":"3","author":"Trottier","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.fct.2018.07.017_bib162","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.12193","article-title":"Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury","volume":"33","author":"Ulzurrun","year":"2013","journal-title":"Liver Int.: Offic. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.fct.2018.07.017_bib163","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"Van de Steeg","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2018.07.017_bib164","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tiv.2017.07.024","article-title":"Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis","volume":"44","author":"Van den Hof","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2018.07.017_bib165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/tx4004165","article-title":"Classification of hepatotoxicants using HepG2 cells: a proof of principle study","volume":"27","author":"Van den Hof","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib166","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","article-title":"Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy","volume":"133","author":"Van Mil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.07.017_bib167","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/toxsci\/kfq380","article-title":"Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells","volume":"120","author":"Van Summeren","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib168","first-page":"71","article-title":"Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen","author":"Van Summeren","year":"2013","journal-title":"Amiodarone, and Cyclosporin A as Model Compounds: An Omics-Guided Approach, OMICS"},{"key":"10.1016\/j.fct.2018.07.017_bib169","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.fct.2018.07.017_bib170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib171","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14740338.2.3.287","article-title":"Drug-induced cholestasis","volume":"2","author":"Velayudham","year":"2003","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.fct.2018.07.017_bib172","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00204-018-2201-4","article-title":"In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist","volume":"92","author":"Vinken","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib173","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib174","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.20039","article-title":"The maintenance and generation of membrane polarity in hepatocytes","volume":"39","author":"Wang","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.fct.2018.07.017_bib175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI0215968","article-title":"The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II","volume":"110","author":"Wang","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2018.07.017_bib176","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/aps.2014.119","article-title":"Resveratrol effectively attenuates alpha-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fct.2018.07.017_bib177","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/acs.chemrestox.6b00337","article-title":"Integrative \"-Omics\" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine a-induced cholestasis","volume":"29","author":"Wolters","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib178","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.taap.2013.09.023","article-title":"Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice","volume":"273","author":"Woolbright","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib179","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bcpt.12449","article-title":"Bile acid-induced toxicity in HepaRG cells recapitulates the response in primary human hepatocytes","volume":"118","author":"Woolbright","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.fct.2018.07.017_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030250","article-title":"Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis","volume":"7","author":"Yamaura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2018.07.017_bib181","doi-asserted-by":"crossref","first-page":"G85","DOI":"10.1152\/ajpgi.2001.281.1.G85","article-title":"Nifedipine modulation of biliary GSH and GSSG\/ conjugate efflux in normal and regenerating rat liver","volume":"281","author":"Yang","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2018.07.017_bib182","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/jps.23584","article-title":"An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters","volume":"102","author":"Yang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.fct.2018.07.017_bib183","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.29327","article-title":"The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat","volume":"67","author":"Yip","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2018.07.017_bib184","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.110.067256","article-title":"Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3\/ABCB4","volume":"79","author":"Yoshikado","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2018.07.017_bib185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yexcr.2016.11.027","article-title":"Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance","volume":"350","author":"Zeigerer","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.fct.2018.07.017_bib186","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2008.12.117","article-title":"Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists","volume":"379","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2018.07.017_bib187","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopha.2017.02.025","article-title":"Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats","volume":"89","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fct.2018.07.017_bib188","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000371695","article-title":"Nuclear receptor variants in liver disease","volume":"33","author":"Zimmer","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.fct.2018.07.017_bib190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000365003","article-title":"Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury","volume":"90","author":"Zollner","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.fct.2018.07.017_bib189","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br. J. Pharmacol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691518304551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691518304551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:44:21Z","timestamp":1759527861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691518304551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":190,"alternative-id":["S0278691518304551"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2018.07.017","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}